Literature DB >> 4045912

Mechanisms in endocrine therapy of bone metastases.

B A Stoll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4045912      PMCID： PMC1289527     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  8 in total

Review 1.  Tamoxifen in advanced breast cancer.

Authors:  H Mouridsen; T Palshof; J Patterson; L Battersby
Journal:  Cancer Treat Rev       Date:  1978-09       Impact factor: 12.111

2.  Response of metastatic breast cancer to combination chemotherapy according to site.

Authors:  J A Russell; J W Baker; P J Dady; H T Ford; J C Gazet; J C McKinna; A G Nash; T J Powles
Journal:  Br Med J       Date:  1977-11-26

3.  Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.

Authors:  C H Chesnut; W B Nelp; D J Baylink; J D Denney
Journal:  Metabolism       Date:  1977-03       Impact factor: 8.694

4.  Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

Authors:  D C Tormey; R M Simon; M E Lippman; J M Bull; C E Myers
Journal:  Cancer Treat Rep       Date:  1976-10

5.  Corticosteroids for elderly patients with breast cancer.

Authors:  M J Minton; R K Knight; R D Rubens; J L Hayward
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

6.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Authors:  I E Smith; A L Harris; M Morgan; H T Ford; J C Gazet; C L Harmer; H White; C A Parsons; A Villardo; G Walsh; J A McKinna
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28

7.  Oestrogen-receptor status and sites of metastasis in breast cancer.

Authors:  F C Campbell; R W Blamey; C W Elston; R I Nicholson; K Griffiths; J L Haybittle
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

8.  Assessment of response to therapy in advanced breast cancer.

Authors:  J L Hayward; P P Carbone; J C Heusen; S Kumaoka; A Segaloff; R D Rubens
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640
  8 in total
  2 in total

Review 1.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

2.  Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

Authors:  L L Shek; W Godolphin; J J Spinelli
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.